1-222627641-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_198551.4(MIA3):āc.421T>Gā(p.Leu141Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000664 in 1,596,186 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_198551.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MIA3 | NM_198551.4 | c.421T>G | p.Leu141Val | missense_variant | 4/28 | ENST00000344922.10 | NP_940953.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MIA3 | ENST00000344922.10 | c.421T>G | p.Leu141Val | missense_variant | 4/28 | 5 | NM_198551.4 | ENSP00000340900 | P1 | |
MIA3 | ENST00000470521.1 | n.433T>G | non_coding_transcript_exon_variant | 4/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152232Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000103 AC: 24AN: 232374Hom.: 1 AF XY: 0.0000794 AC XY: 10AN XY: 125942
GnomAD4 exome AF: 0.0000616 AC: 89AN: 1443836Hom.: 0 Cov.: 31 AF XY: 0.0000627 AC XY: 45AN XY: 717704
GnomAD4 genome AF: 0.000112 AC: 17AN: 152350Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74494
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 16, 2023 | The c.421T>G (p.L141V) alteration is located in exon 4 (coding exon 4) of the MIA3 gene. This alteration results from a T to G substitution at nucleotide position 421, causing the leucine (L) at amino acid position 141 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at